A hyper-IgM2 AID mutation limits IgH break formation but preserves affinity maturation.

IF 7.7 1区 生物学 Q1 CELL BIOLOGY
Kalina T Belcheva, Priyanka Chowdhury, Vivian L S Kuan, William Alread, Dulguun Baasan, Jennifer K Lue, Stephanie Downs-Canner, Richard L Frock, William T Yewdell, Jayanta Chaudhuri
{"title":"A hyper-IgM2 AID mutation limits IgH break formation but preserves affinity maturation.","authors":"Kalina T Belcheva, Priyanka Chowdhury, Vivian L S Kuan, William Alread, Dulguun Baasan, Jennifer K Lue, Stephanie Downs-Canner, Richard L Frock, William T Yewdell, Jayanta Chaudhuri","doi":"10.1016/j.celrep.2026.118221","DOIUrl":null,"url":null,"abstract":"<p><p>Activation-induced cytidine deaminase (AID) drives antibody diversification through class switch recombination (CSR) and somatic hypermutation (SHM). Humans with an AID mutation deleting the last nine amino acids (AID<sup>R190X</sup>) develop hyper-IgM syndrome with defective CSR but variable SHM, suggesting that the C terminus plays a marked role in CSR. To model this putative separation-of-function mutation, we generated an Aicda<sup>R190X</sup> knock-in mouse. These mice show a severe CSR defect and a moderately reduced but ongoing SHM. Mechanistically, the severe CSR defect correlates with defective recombination of double-strand breaks in immunoglobulin switch regions. Strikingly, fusion of AID<sup>R190X</sup> to a catalytically inactive AID restores CSR, indicating that the C terminus mediates a non-catalytic function for recombination. This mouse model of the human R190X mutation demonstrates that the AID C terminus is indispensable for CSR and also contributes to efficient SHM, providing insight into the mechanistic basis of hyper-IgM immunodeficiency.</p>","PeriodicalId":9798,"journal":{"name":"Cell reports","volume":"45 11","pages":"118221"},"PeriodicalIF":7.7000,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell reports","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.celrep.2026.118221","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Activation-induced cytidine deaminase (AID) drives antibody diversification through class switch recombination (CSR) and somatic hypermutation (SHM). Humans with an AID mutation deleting the last nine amino acids (AIDR190X) develop hyper-IgM syndrome with defective CSR but variable SHM, suggesting that the C terminus plays a marked role in CSR. To model this putative separation-of-function mutation, we generated an AicdaR190X knock-in mouse. These mice show a severe CSR defect and a moderately reduced but ongoing SHM. Mechanistically, the severe CSR defect correlates with defective recombination of double-strand breaks in immunoglobulin switch regions. Strikingly, fusion of AIDR190X to a catalytically inactive AID restores CSR, indicating that the C terminus mediates a non-catalytic function for recombination. This mouse model of the human R190X mutation demonstrates that the AID C terminus is indispensable for CSR and also contributes to efficient SHM, providing insight into the mechanistic basis of hyper-IgM immunodeficiency.

超igm2 AID突变限制了IgH断裂的形成,但保留了亲和成熟。
激活诱导胞苷脱氨酶(AID)通过类开关重组(CSR)和体细胞超突变(SHM)驱动抗体多样化。AID突变删除最后9个氨基酸(AIDR190X)的人会出现高igm综合征,伴有CSR缺陷,但SHM可变,这表明C端在CSR中起着显著作用。为了模拟这种假定的功能分离突变,我们制造了一只AicdaR190X敲入小鼠。这些小鼠表现出严重的CSR缺陷和中度减少但持续的SHM。从机制上讲,严重的CSR缺陷与免疫球蛋白开关区双链断裂的缺陷重组有关。引人注目的是,AIDR190X与无催化活性的AID融合可恢复CSR,这表明C端介导了重组的非催化功能。这种人类R190X突变的小鼠模型表明,AID C末端对于CSR是必不可少的,也有助于高效的SHM,从而深入了解超igm免疫缺陷的机制基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cell reports
Cell reports CELL BIOLOGY-
CiteScore
13.80
自引率
1.10%
发文量
1305
审稿时长
77 days
期刊介绍: Cell Reports publishes high-quality research across the life sciences and focuses on new biological insight as its primary criterion for publication. The journal offers three primary article types: Reports, which are shorter single-point articles, research articles, which are longer and provide deeper mechanistic insights, and resources, which highlight significant technical advances or major informational datasets that contribute to biological advances. Reviews covering recent literature in emerging and active fields are also accepted. The Cell Reports Portfolio includes gold open-access journals that cover life, medical, and physical sciences, and its mission is to make cutting-edge research and methodologies available to a wide readership. The journal's professional in-house editors work closely with authors, reviewers, and the scientific advisory board, which consists of current and future leaders in their respective fields. The advisory board guides the scope, content, and quality of the journal, but editorial decisions are independently made by the in-house scientific editors of Cell Reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书